Heron Therapeutics Inc (HRTX) stock has gained 67.70% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives HRTX stock a score of 80 out of a possible 100.
That rank is influenced by a long-term technical score of 83. HRTX's rank also includes a short-term technical score of 66.
HRTX has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on HRTX!
Heron Therapeutics Inc (HRTX) stock is down -1.46% while the S&P 500 has gained 0.22% as of 11:31 AM on Wednesday, Mar 27. HRTX is lower by -$0.04 from the previous closing price of $2.74 on volume of 398,814 shares. Over the past year the S&P 500 is up 31.32% while HRTX has gained 67.70%. HRTX lost -$0.80 per share in the over the last 12 months.
Click Here to get the full Stock Report for Heron Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
